Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Ravimiuskumuste küsimustik (BMQ)× | Medication Adherence Rating Scale (MARS)× | |
|---|---|---|
| Valdkond | Farmakoloogia | Farmakoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1999 | 2000 |
| Looja≠ | Rob Horne, John Weinman, and Michelle Hankins | Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew |
| Tüüp | Self-report | Self-report |
| Algallikas≠ | Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1-24. DOI ↗ | Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247. DOI ↗ |
| Rööpnimetused | BMQ | MARS |
| Seotud | 4 | 4 |
| Kokkuvõte≠ | The Beliefs about Medicines Questionnaire (BMQ) is an 18-item self-report measure developed by Horne, Weinman, and Hankins in 1999 to assess patients' cognitive beliefs about necessity of medications and concerns about potential adverse effects. It is widely used in clinical research to predict medication adherence, particularly in chronic disease management, and has demonstrated strong predictive validity across diverse populations and disease contexts. | The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors. |
| ScholarGateAndmestik ↗ |
|
|